Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.1K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

8.5K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.5K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.3K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.2K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
Pleiotropy01:33

Pleiotropy

42.1K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
42.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miRNA family miR-29 inhibits PINK1-PRKN signaling via ATG9A.

Molecular neurodegeneration advances·2026
Same author

A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions.

Nature genetics·2026
Same author

Describing the diversity of <i>MAPT</i> transcripts in the parietal cortex of Pick's disease patients.

NPJ dementia·2026
Same author

Novel Aggressive Subtype of Multiple System Atrophy Identified by Unsupervised Machine Learning.

Annals of neurology·2026
Same author

The Assessment of RAB32 p.Ser71Arg Variant Prevalence in Parkinson's Disease Across Selected African, European, and South American Cohorts.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease.

Annals of neurology·2025

Related Experiment Video

Updated: Nov 17, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.3K

Investigating ELOVL7 coding variants in multiple system atrophy.

Anna I Wernick1, Ronald L Walton2, Alexandra I Soto-Beasley2

  • 1Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA; School of Biological Sciences, University of Manchester, Manchester, UK; Queen Square Institute of Neurology, University College London, London, UK.

Neuroscience Letters
|February 18, 2021
PubMed
Summary
This summary is machine-generated.

Genetic analysis of the ELOVL7 gene revealed no significant association with Multiple System Atrophy (MSA) risk. This study investigated coding variants in ELOVL7, finding them to be rare and not linked to MSA development.

Keywords:
ELOVL7GeneticsLipidsMultiple system atrophySynucleinopathy

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

764
A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
06:35

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants

Published on: October 10, 2022

2.2K

Related Experiment Videos

Last Updated: Nov 17, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.3K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

764
A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
06:35

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants

Published on: October 10, 2022

2.2K

Area of Science:

  • Neurogenetics
  • Neurodegenerative Diseases
  • Genomic Association Studies

Background:

  • Multiple system atrophy (MSA) is a rare, progressive parkinsonism with autonomic dysfunction.
  • Previous research suggested a potential link between the ELOVL7 gene locus and MSA risk.
  • Understanding the genetic underpinnings of MSA is crucial for identifying potential therapeutic targets.

Purpose of the Study:

  • To investigate the association of coding variants in the Elongation of Very Long Fatty Acids Protein 7 (ELOVL7) gene with the risk of developing Multiple System Atrophy (MSA).
  • To validate or refute the findings of a prior genome-wide association study implicating the ELOVL7 locus in MSA susceptibility.

Main Methods:

  • Sequencing of all exons of the ELOVL7 gene in pathologically confirmed MSA cases.
  • Analysis of whole genome sequence data for ELOVL7 variants in Parkinson's disease (PD) cases and healthy control cohorts.
  • Assessment across four independent cohorts, including pathologically confirmed MSA, PD, and healthy controls.

Main Results:

  • Coding variants within the ELOVL7 gene were found to be extremely rare across all assessed cohorts.
  • No statistically significant association was observed between ELOVL7 coding variants and the risk of Multiple System Atrophy (MSA).
  • The findings do not support a direct role of ELOVL7 coding variants in the pathogenesis of MSA.

Conclusions:

  • The study did not find evidence to support the association of ELOVL7 coding variants with Multiple System Atrophy (MSA) risk.
  • Further research may be needed to explore non-coding regions or other genetic factors influencing MSA susceptibility.
  • ELOVL7 coding variants are unlikely to be major determinants of MSA risk in the studied populations.